SOPH vs TEM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SOPH · Sophia Genetics$6.23 ▼ 6.74%
TEM · Tempus AI$54.04 ▼ 9.34%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SOPH +28.2%
- TEM -29.0%
Head to head
| Metric | SOPH | TEM |
|---|---|---|
| Price | $6.23 | $54.04 |
| Change today | ▼ 6.74% | ▼ 9.34% |
| Market cap | $533.65M | $9.86B |
| Return, 3 months | -26.3% | -18.3% |
| Return, year to date | +33.4% | -8.5% |
| Return, 1 year | +37.2% | -23.1% |
| P/E (TTM) | – | – |
| P/B | 7.7 | 19.7 |
| P/E percentile vs own 5y | 6th | 25th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +24.7% | +23.1% |
| Net profit growth (YoY) | -1.3% | +81.4% |
| Gross margin | 66.4% | 64.5% |
| Operating margin | -81.0% | -18.5% |
| Net margin | -89.2% | -12.5% |
| Return on equity | -125.7% | -37.5% |
| Analyst target vs. price | +84.6% | +63.8% |
| Analyst buy share | 100% | 62% |
| RSI (14) | 37 | 33 |
| 30-day volatility | 82.1% | 90.9% |
| Max drawdown, 1 year | -30.2% | -46.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TEM is the largest of the group by market value.
- SOPH has returned the most over the past year.
- SOPH is growing revenue fastest.
- TEM keeps the most profit per dollar of sales.
- SOPH has been the calmest stock over the last 30 days.